517 related articles for article (PubMed ID: 22029759)
21. Early detection of prostate cancer. Role of prostate-specific antigen.
Prabhakaran VM
Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
[TBL] [Abstract][Full Text] [Related]
22. PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.
Kearns JT; Holt SK; Wright JL; Lin DW; Lange PH; Gore JL
Cancer; 2018 Jul; 124(13):2733-2739. PubMed ID: 29781117
[TBL] [Abstract][Full Text] [Related]
23. Prostate specific antigen and screening for early prostate cancer.
Davidson P
N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
[No Abstract] [Full Text] [Related]
24. Prostate cancer screening.
Med Lett Drugs Ther; 2008 Nov; 50(1298):85-6. PubMed ID: 18978703
[No Abstract] [Full Text] [Related]
25. Counseling patients about prostate cancer screening.
Foxhall LE; Von Eschenbach AC
Am Fam Physician; 2002 May; 65(9):1752, 1754, 1757. PubMed ID: 12018801
[No Abstract] [Full Text] [Related]
26. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761
[No Abstract] [Full Text] [Related]
27. Randomized trial results did not resolve controversies surrounding prostate cancer screening.
Hoffman RM
Curr Opin Urol; 2010 May; 20(3):189-93. PubMed ID: 20224414
[TBL] [Abstract][Full Text] [Related]
28. New prostate cancer screening guidelines.
Wartinger DD
J Am Osteopath Assoc; 1993 Jul; 93(7):736. PubMed ID: 7690013
[No Abstract] [Full Text] [Related]
29. Prostate Cancer Screening and the Associated Controversy.
Tabayoyong W; Abouassaly R
Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
[TBL] [Abstract][Full Text] [Related]
30. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2012 Jul; 157(2):120-34. PubMed ID: 22801674
[TBL] [Abstract][Full Text] [Related]
31. Missing the mark on prostate-specific antigen screening.
Miller DC; Hollenbeck BK
JAMA; 2011 Dec; 306(24):2719-20. PubMed ID: 22203542
[No Abstract] [Full Text] [Related]
32. Prostate cancer screening--time to abandon one-size-fits-all approach?
Kim J; Davis JW
JAMA; 2011 Dec; 306(24):2717-8. PubMed ID: 22203541
[No Abstract] [Full Text] [Related]
33. Evolving detection and treatment methods change approaches to prostate cancer: US Preventive Services Task Force draft recommendations now align more closely with others.
Printz C
Cancer; 2018 Jan; 124(1):11-12. PubMed ID: 29251768
[No Abstract] [Full Text] [Related]
34. Prostate cancer. When to offer screening in the primary care setting.
Gambert SR
Geriatrics; 2001 Jan; 56(1):22-6, 29-31. PubMed ID: 11196336
[TBL] [Abstract][Full Text] [Related]
35. Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
Joshi SS; Filson CP
Cancer; 2020 Feb; 126(4):694-696. PubMed ID: 31794066
[No Abstract] [Full Text] [Related]
36. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in Australia.
Zargar H; van den Bergh R; Moon D; Lawrentschuk N; Costello A; Murphy D
BJU Int; 2017 Jan; 119(1):110-115. PubMed ID: 27454454
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer.
Shteynshlyuger A; Andriole GL
J Urol; 2011 Mar; 185(3):828-32. PubMed ID: 21239021
[TBL] [Abstract][Full Text] [Related]
38. Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.
Eapen RS; Herlemann A; Washington SL; Cooperberg MR
Curr Opin Urol; 2017 May; 27(3):205-209. PubMed ID: 28221220
[TBL] [Abstract][Full Text] [Related]
39. Risk factors, prevention and early detection of prostate cancer.
Loeb S; Schaeffer EM
Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
[TBL] [Abstract][Full Text] [Related]
40. Screening for prostate cancer: informing men about their options.
Mahon SM
Clin J Oncol Nurs; 2005 Oct; 9(5):625-7. PubMed ID: 16235590
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
